visual identification test of the cogstate computerized cognitive testing battery (CogState Ltd)
90
Structured Review
CogState Ltd
visual identification test of the cogstate computerized cognitive testing battery
Visual Identification Test Of The Cogstate Computerized Cognitive Testing Battery, supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visual+identification+test+of+the+cogstate+computerized+cognitive+testing+battery/visual+identification+test+of+the+cogstate+computerized+cognitive+testing+battery/pmc07537630-18-58-54
Average 90 stars, based on 1 article reviews
Visual Identification Test Of The Cogstate Computerized Cognitive Testing Battery, supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visual+identification+test+of+the+cogstate+computerized+cognitive+testing+battery/visual+identification+test+of+the+cogstate+computerized+cognitive+testing+battery/pmc07537630-18-58-54
Average 90 stars, based on 1 article reviews
visual identification test of the cogstate computerized cognitive testing battery - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Mutagenesis:Article Title: Clinical trials in mitochondrial disorders, an update Article Snippet: Sonlicromanol (KH176) , An exploratory, double-blind, randomized, placebo-controlled, single-center, two-way cross-over study with KH176 in patients with the mitochondrial DNA tRNALeu (UUR) m.3243A>G mutation and clinical signs of mitochondrial disease (The KHENERGY study) ( NCT02909400 ) , Motor abnormalities and movement characteristics (Time frame: one month) , Completed; no significant improvement in gait parameters or other outcome measures, except for a positive effect on alertness and mood. .. A phase IIb double-blind, randomized, placebo-controlled, multi-centre, confirmative three-way cross-over study on cognitive function with two doses of KH176 in subjects with a genetically confirmed mitochondrial DNA tRNALeu (UUR) m.3243A>G mutation (The KHENERGYZE study) ( NCT04165239 ) , The attention domain score of cognitive functioning, as assessed by the Battery:Article Title: Clinical trials in mitochondrial disorders, an update Article Snippet: Sonlicromanol (KH176) , An exploratory, double-blind, randomized, placebo-controlled, single-center, two-way cross-over study with KH176 in patients with the mitochondrial DNA tRNALeu (UUR) m.3243A>G mutation and clinical signs of mitochondrial disease (The KHENERGY study) ( NCT02909400 ) , Motor abnormalities and movement characteristics (Time frame: one month) , Completed; no significant improvement in gait parameters or other outcome measures, except for a positive effect on alertness and mood. .. A phase IIb double-blind, randomized, placebo-controlled, multi-centre, confirmative three-way cross-over study on cognitive function with two doses of KH176 in subjects with a genetically confirmed mitochondrial DNA tRNALeu (UUR) m.3243A>G mutation (The KHENERGYZE study) ( NCT04165239 ) , The attention domain score of cognitive functioning, as assessed by the |